tetraiodothyroacetic acid has been researched along with docetaxel anhydrous in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cui, H; Fu, R; Hu, M; Li, C; Li, M; Li, X; Li, Z; Lu, L; Luo, M; Sheng, F; Shi, S; Wu, G; Xiang, M; Xu, J; Zhang, Q; Zhou, M | 1 |
1 other study(ies) available for tetraiodothyroacetic acid and docetaxel anhydrous
Article | Year |
---|---|
Synergistic active targeting of dually integrin αvβ3/CD44-targeted nanoparticles to B16F10 tumors located at different sites of mouse bodies.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Docetaxel; Drug Liberation; Female; Humans; Hyaluronan Receptors; Hyaluronic Acid; Integrin alphaVbeta3; MCF-7 Cells; Mice, Inbred C57BL; Nanoparticles; Neoplasms; Taxoids; Thyroxine; Tumor Burden; Xenograft Model Antitumor Assays | 2016 |